Position in RDNT
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$45,063,883
-$9,766,023 QoQ
Shares Held
806,296
+4.9% QoQ
Ownership
1.02%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in RDNT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FULLER & THALER ASSET MANAGEMENT, INC. holds $741,523,491 across 11 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
2,629,007 | $394,429,920 | |
| 2 | MEDP |
Medpace Holdings, Inc.
|
230,555 | $122,099,622 | |
| 3 | VCYT |
Veracyte, Inc.
|
1,509,749 | $88,667,558 | |
| 4 | WAT |
Waters Corp /De/
|
190,721 | $71,528,003 | |
| 5 | BLLN |
BillionToOne, Inc.
|
418,565 | $50,219,428 | |
| 6 | DGX |
Quest Diagnostics Inc
|
31,605 | $6,698,679 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
17,149 | $3,313,529 | |
| 8 | A |
Agilent Technologies, Inc.
|
17,377 | $2,308,186 |
All Filings in RDNT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $45,063,883 | 806,296 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $54,829,906 | 768,464 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $53,778,272 | 705,659 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||